[Is enoxaparine (PK 10169) a good anticoagulant in chronic hemodialysis?].
Tolerance and efficacy of single i. v. injections of PK 10169 (1 mg/kg) during installation were evaluated in 10 patients with stable chronic renal insufficiency treated with 3 sessions of hemodialysis weekly (sessions of 4 and 5 hours). Tolerance was good in all cases. Efficacy was globally satisfactory (no complete coagulation) but by the 4th hour in 7 out of 30 sessions coagulation was apparent in the bubble trap with elevation of residual blood volume, recurring in the same patient but not affecting result of dialysis. In these cases anti-Xa activity was reduced from the 2nd hour and at end of dialysis, with a markedly elevated FPA level. For most patients it is possible to envisage 5-hour sessions, but in those few susceptible to develop coagulation repeated clinical surveillance of all circuit elements is necessary.
Briquel
M E
ME
Laboratoire d'Hémostase, C.R.T.S. de Nancy.
Kessler
M
M
André
E
E
Huu
T C
TC
Alexandre
P
P
Renoult
E
E
Jonon
B
B
D000328:Adult; D000368:Aged; D001777:Blood Coagulation / Q000187:drug effects*; D001810:Blood Volume / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
D006495:Heparin, Low-Molecular-Weight
L'énoxaparine (PK 10,169) est-elle un bon anticoagulant dans l'hémodialyse itérative?